Description
Atriopeptin I is an analog of atrial natriuretic peptide (ANP) that exhibits some vasodilatory/hypotensive activities, but is significantly less potent than ANP and other ANP analogs.
Atriopeptin I is an analog of atrial natriuretic peptide (ANP) that exhibits some vasodilatory/hypotensive activities, but is significantly less potent than ANP and other ANP analogs.
| Purity | ≥95% |
|---|---|
| Formula | C83H135N29O30S2 |
| Formula Wt. | 2083.31 |
| Solubility | Soluble in water, acid. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Stewart AG, Thompson JS, Rogers TK, et al. Atrial natriuretic peptide-induced relaxation of pre-constricted isolated rat perfused lungs: a comparison in control and hypoxia-adapted animals. Clin Sci (Lond). 1991 Aug;81(2):201-8. PMID: 1653664.
Numan NA, Gillespie MN, Altiere RJ. Pulmonary vasorelaxant activity of atrial peptides. Pulm Pharmacol. 1990;3(1):29-33. PMID: 1966900.
Folic acid derivative
Trichothecene mycotoxin produced by Fusarium.
Neuropeptide found in insects; juvenile hormone...
2-methyl-1,4-naphthoquinone derivative
Sulforaphane-cysteine conjugate.
SIRT1/2 inhibitor.
EGFR inhibitor.
Type A trichothecene mycotoxin produced by Fusa...
Peptide, used to study cell-surface binding; po...
Caspase 3 substrate.
MET inhibitor.
PLK1 inhibitor.
Pleuromutilin
Fermentation impurity
H+/K+ ATPase inhibitor.
Triazole; gibberellin inhibitor, potential 14-Î...
SIRT2 inhibitor.
Endogenous peptide neurotransmitter, involved i...
PDE5/6 inhibitor.